Your browser doesn't support javascript.
loading
Detection of temozolomide-induced hypermutation and response to PD-1 checkpoint inhibitor in recurrent glioblastoma.
Daniel, Paul; Meehan, Brian; Sabri, Siham; Jamali, Fatemeh; Sarkaria, Jann N; Choi, Dongsic; Garnier, Delphine; Kitange, Gaspar; Glennon, Kate I; Paccard, Antoine; Karamchandani, Jason; Riazalhosseini, Yasser; Rak, Janusz; Abdulkarim, Bassam.
Afiliación
  • Daniel P; Department of Oncology, McGill University, Research Institute of the McGill University Health Centre (Research Institute-MUHC), Montreal, Canada.
  • Meehan B; McGill University, Research Institute of the McGill University Health Centre (Research Institute-MUHC), Montreal, Canada.
  • Sabri S; Research Institute, Cancer Research Program, McGill University Health Centre, Glen Site, 1001 Decarie Boulevard, Montreal, Quebec H4A 3J1, Canada.
  • Jamali F; McGill University, Research Institute of the McGill University Health Centre (Research Institute-MUHC), Montreal, Canada.
  • Sarkaria JN; Mayo Clinic, Department of Radiation Oncology.
  • Choi D; McGill University, Research Institute of the McGill University Health Centre (Research Institute-MUHC), Montreal, Canada.
  • Garnier D; McGill University, Research Institute of the McGill University Health Centre (Research Institute-MUHC), Montreal, Canada.
  • Kitange G; Mayo Clinic, Department of Radiation Oncology.
  • Glennon KI; McGill University, McGill Genome Centre.
  • Paccard A; McGill University, McGill Genome Centre.
  • Karamchandani J; Department of Pathology, McGill University, Montreal, Canada.
  • Riazalhosseini Y; McGill University, McGill Genome Centre.
  • Rak J; Department of Pediatrics, McGill University Health Centre, Glen Site, 1001 Decarie Boulevard, Montreal, QC H4A 3J1, Canada.
  • Abdulkarim B; Department of Oncology, McGill University, Research Institute of the McGill University Health Centre (Research Institute-MUHC), Montreal, Canada.
Neurooncol Adv ; 4(1): vdac076, 2022.
Article en En | MEDLINE | ID: mdl-35795471

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Neurooncol Adv Año: 2022 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Neurooncol Adv Año: 2022 Tipo del documento: Article País de afiliación: Canadá